本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2014/7/91 分钟阅读
Public Meeting on Patient-Focused Drug Development for Hemophilia A, Hemophilia B, von Willebrand Disease, and Other Heritable Bleeding Disorders
本地自动翻译 · 来源原始语言
摘要
Public Meeting on Patient-Focused Drug Development for Hemophilia A, Hemophilia B, von Willebrand Disease, and Other Heritable Bleeding Disorders
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →